Compound 915
Identifiers
- Canonical SMILES:
CNC(=O)c1nc(-c2ccccc2)n(c1-c1cccc(Cl)c1)-c1cccc(Cl)c1
- IUPAC name:
1,5-bis(3-chlorophenyl)-N-methyl-2-phenylimidazole-4-carboxamide
- InChi:
InChI=1S/C23H17Cl2N3O/c1-26-23(29)20-21(16-9-5-10-17(24)13-16)28(19-12-6-11-18(25)14-19)22(27-20)15-7-3-2-4-8-15/h2-14H,1H3,(H,26,29)
- InChiKey:
KXXHNNPNEGWABI-UHFFFAOYSA-N
External links
50996419 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.63 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 421.07 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 5.24 | |||
TPSA | 46.92 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 14 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.63 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4636 | Flumazenil | DB01205 | |
0.4570 | Iomazenil | DB14971 | |
0.4546 | L-778123 | DB07227 | |
0.4516 | Conivaptan | DB00872 | |
0.4498 | Azeliragon | DB12689 | |
0.4415 | AZD-7687 | DB14949 | |
0.4339 | PF-03463275 | DB11993 | |
0.4270 | 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide | DB03509 | |
0.4190 | Cimicoxib | DB05095 | |
0.4022 | ONT-093 | DB14069 | |
0.4000 | Miransertib | DB14982 | |
0.3990 | Basimglurant | DB11833 | |
0.3942 | N-6022 | DB12206 | |
0.3936 | 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine | DB08521 | |
0.3930 | Otenabant | DB11745 |